I’ve lived two lives—one as a fashion model showing only the surface of me, and now as an artist where I can reveal what’s ...
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...
A child waits last year in the daycare at Faith Presbyterian Church for her mother to get out of an English language class for refugee women from Afghanistan. Such families are trying to do exactly ...
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Minjuvi ® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with ...